The Information in this section is intended for healthcare professionals only.

Please confirm that you are a healthcare professional.

The Information in this section is intended for healthcare professionals only.

Please confirm that you are a healthcare professional.

Cookies

This site uses cookies for site interaction analysis with a purpose of service quality enhancing and uninterrupted site work. More details in Cookies Policy
Accept
30 June 2019

Darnitsa Becoming a Member of the European Business Association

30 June 2019

The Pharmaceutical Firm Darnitsa joined the leading non-governmental business community – the European Business Association (ЕВА). It combines companies that conduct their business transparently, on an anti-corruption basis, in accordance with the principles of ethics.

Now Darnitsa, which is the leader of Ukraine in manufacturing of medicinal products by volume, has become a member of the European Business Association (ЕВА). Darnitsa will join the association’s activities in the area of improvement of the investment climate, transparency and ethics business environment in Ukraine and improvement of legislation relating, in particular, to the pharmaceutical industry. The company has a strong team of specialists in various fields, they will work in the EBA committees in order to solve the issues that are important for the development of the industry, society, economy and the country in general.

Dmytro Shymkiv, Chairman of the Board of Directors of Darnitsa Group

Joining ЕВА is a logical step in the development of Darnitsa since it indicates that the company runs its business in line with European values. Our production meets the GMP (Good Manufacturing Practice) requirements. The transparency and compliance of the business is confirmed with annual financial and legal audits. The responsibility to all stakeholders is a priority for “Darnitsa”.

We see the participation in solving issues that are important for the country’s investment climate and development of the Ukrainian pharmaceutical industry as our key tasks in the cooperation with the ЕВА.

Over the last three year pharmaceutics has become the driver of the national economy and has shown the average growth of 11% per year which is triple faster than that of the Ukrainian economy as a whole. The industry creates 0.83% of the country’s GDP and provides UAH 24 billion of added value.
Together with the market, “Darnitsa” shows the financial stability of growth. Since 2016 the company’s net revenues from sale of products have been annually increasing by an average of 18.6%, its net profit by 15.7%.

Anna Derevianko, Executive Director of the European Business Association

The European Business Association was founded in 1999. Since then we have grown to become the most influential and the largest business association in Ukraine. Today it is a community of nearly 1,000 companies in 5 regions – Kyiv, Lviv, Odesa, Kharkiv and Dnipro. These are businesses from a variety of industries, e.g. pharmaceutics, logistics, IT, etc., united in committees and today there are 23 of them. We work in order to give our companies the opportunity to solve the issues that are important for the Ukrainian investment climate and to improve it to the benefit of the industry, society, economy and the country in general by joining efforts. And we are always happy to welcome to our folds new and progressive companies like Darnitsa. Because it’s only through joint efforts that we can influence the conditions of doing business in the country.

Today the ЕВА is the most influential and the largest business association in Ukraine. The ЕВА has been operating in the Ukrainian market for 20 years already and numbers nearly 1,000 domestic and international companies from 59 countries of the world. Due to the ЕВА, the companies get assistance in establishing partnership relations with the government and establishing business relations with international and Ukrainian companies.

Darnitsa has been the leader in the sale of medicinal products by volume since 1998. The Company majors in the manufacturing of solid dosage forms, solutions for injections in ampoules, drops, semisolid dosage forms, sterile powders for solutions for injections and infusion solutions. The Company’s portfolio includes nearly 250 names of finished medicinal products. The products of Darnitsa are exported to 16 countries.

Share:
Specialized edition for medical institutions and doctors.